Immune response to B19 parvovirus and an antibody defect in persistent viral infection - Wikidata - wikimedia - TriplyDB

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

http://www.wikidata.org/entity/Q35815343

about

Human parvovirus B19.Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation.Association between human parvovirus B19 infection and arthritis Impaired gamma interferon responses against parvovirus B19 by recently infected children.Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins Status of immunity against PVB19 in HIV-infected patients according to CD4(+) cell count, and antiretroviral therapy regimen groups.SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR.New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.Pathogenesis of human parvovirus B19 in rheumatic disease.Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.Parvovirus B19 infection in pediatric transplant patients Erythema infectiosum and pregnancy-related complications Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report.Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins.Parvovirus vectors for cancer gene therapy.Parvovirus B-19 infection during pregnancy.Parvovirus particles as platforms for protein presentation Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation High prevelance of human parvovirus infection in patients with malignant tumors.Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China.Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections Anemia of Central Origin.Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens.Effects of human parvovirus B19 VP1 unique region protein on macrophage responses.Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19 Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.

P2860

Q24532891-86B78295-A60E-4A5B-A3EA-F8885C42C989 Q24792864-29DFB8F5-C00C-4C16-8E34-95C2FBD71FA8 Q33338991-FDCBB153-D805-4195-9674-7F801120A6D3 Q33578106-50FBDE87-2F28-41DA-9579-9EA8B6E8EB51 Q33603469-9D0C3FDF-0186-4980-B5E4-F97DFB14E71C Q33653001-B16D45BE-54B2-49CC-B6C5-CF5BB3CDA663 Q33809249-D5622DEB-81C2-4721-8B52-EFD547A62794 Q33824586-F5356FEB-1EF3-4F28-97FF-F4CC697CCE23 Q33946939-F01218E2-51E4-4611-99BC-E20D2C4ED208 Q33974299-1A3ED9B7-9529-41B7-8804-69A9298A2EF2 Q33982832-2DAE260B-FEAD-4A20-9C7B-6A69E5C73B18 Q34024904-B92288F9-6549-468E-AF30-24EAC4F9D7AB Q34120900-D46A5C6A-124A-4AAE-B54A-A2894381B176 Q34222176-956D7E4E-1A3D-4CCD-92ED-A72FD150E2A1 Q34299511-B15AA50B-3C68-4762-A206-D81B5D945FB5 Q34578770-A66B9805-FA13-43A0-991B-A442E70A74AB Q35078195-E36AD554-510A-43FC-BA70-477AC565082E Q35139637-22E34A46-8F73-4D17-8CBB-F1EB1A827C26 Q35226239-8BED0FC7-D562-4187-81E2-E5D5F4C67DFF Q35609780-987E9EA8-5584-47A4-ADC5-EC2DA0FA798F Q35691814-099378E2-C261-4822-805E-F4C9672BBD5C Q35722126-D1CF9E97-E041-42C2-ADAE-2D08F0029941 Q35849277-4B000BA4-251B-4E97-8A96-CF463E94D666 Q35995775-BCD74858-265A-4061-87E3-E3A5A9BE1F90 Q36393530-E6CA29FB-BC9D-46BF-8A27-C1ADF7899D9C Q36527536-84ABD21A-9393-4419-A22E-01ED5D84F0B0 Q36646671-068328EB-C83C-46C1-9C37-63741F94F6F6 Q36683366-90C9B9F8-19DA-441C-8E8A-9B8A13F33E41 Q36735626-42346917-9788-4661-814A-C03831F291EB Q36747943-39153112-21A9-4C11-B8A5-EFDEE2696802 Q36784115-58B684C9-851D-4C00-A4FC-D45A5A61F8B3 Q36797386-2EC1355C-E141-417F-9E5A-434DC2B0C1FB Q37064067-2551065C-B2C6-467A-B4AD-63E384C50C8A Q37090584-FB971ED0-4951-4CFA-8665-C20CF4CE3661 Q37122784-874A9002-787D-4965-9DA1-7652F5A140D8 Q37197356-AFE869CC-E74C-4FCF-BD7B-F463E41F7779 Q37239480-D5F63420-EDA9-43AE-A1A6-7940C9F0CBB6 Q37336824-54492532-9A9C-4934-A54C-140FCA95865C Q37378794-0553A176-06CC-4AED-8A2E-37665703F763 Q37410780-E9624A6C-CFF3-4D9D-AE34-2A44092AD347

P2860

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

http://www.wikidata.org/entity/Q35815343

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

1989年论文

@zh

1989年论文

@zh-cn

name

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@ast

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@en

type

label

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@ast

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@en

prefLabel

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@ast

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@en

P1433

Q35815343-F318BBC0-C797-467B-93A2-0CBB23A45C7A

P1476

Q35815343-C14B644B-6DAB-4397-A1A0-3055DEBCF383

P2093

Q35815343-1772F77F-BA8E-4D05-AC49-A6EEE69714F5

Q35815343-3C14BCB9-6F57-4CF5-A172-154BD8D1CEC8

Q35815343-A54CB281-9B73-4A4B-84A7-ECE6C938CEA4

Q35815343-A91A4EE6-49CF-4F8B-9F34-7FC4F3FCD47B

Q35815343-DD13BA63-AC13-4B64-9E6E-9719900A292B

Q35815343-E2C8619E-798B-4ACB-9C80-569546A7D7FF

P2860

Q35815343-046C666F-57E9-472A-B5C7-E377684A1CBB

Q35815343-2B607D89-9820-4D2A-8114-AD96125A8088

Q35815343-2BAA89B0-C6F9-49DA-92BC-A50FB8F0DFC4

Q35815343-2C7456CD-8426-4720-B69E-78423073825A

Q35815343-32B9E3AA-93AA-467B-A87B-250FC03DE578

Q35815343-334F6784-9F4B-4B0B-8340-6DF734968F55

Q35815343-3EC21462-83D2-4001-9646-DEB95F8FFAA5

Q35815343-3F9ABABD-EF30-448D-B071-E6886CE4BEFF

Q35815343-49443382-2A05-44B7-A4A1-2E3470760A5B

Q35815343-4A85723A-1959-42B8-B2E5-C2DEC1E47E15

P304

Q35815343-F44FC13A-F08D-434E-A37C-D7071E6BF9A8

P31

Q35815343-29F63004-D6AF-47BB-A5A1-722FE3AC7D27

P356

Q35815343-EE951714-C073-4D8E-8C3B-78633C19B66B

P407

Q35815343-997A2536-7926-475A-9B92-247893060A44

P433

Q35815343-8BB455F1-C5F8-4F5F-B3A5-057C7FCE7420

P478

Q35815343-F530D321-0B8D-4B6C-AD8C-B06D7842EDE1

P577

Q35815343-74D00A01-26E4-4BF6-B62A-61E7A7D0F053

P5875

Q35815343-50C978EE-D1D9-46C9-8BCA-2CF599B112E7

P698

Q35815343-EEF55418-4A0C-4226-98AA-02D4900C0ED1

P921

Q35815343-DC5718EC-F72D-43B2-B91B-2AB87944AE2E

P932

Q35815343-7358AB71-0A70-47B4-B2FD-8A9351D54FF7

P356

P1433

Journal of Clinical Investigation

P1476

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

@en

P2093

Blaese RM

http://www.w3.org/2001/XMLSchema#string

Cohen BJ

http://www.w3.org/2001/XMLSchema#string

Field AM

http://www.w3.org/2001/XMLSchema#string

Kurtzman GJ

http://www.w3.org/2001/XMLSchema#string

Oseas R

http://www.w3.org/2001/XMLSchema#string

Young NS

http://www.w3.org/2001/XMLSchema#string

P2860

Replication of porcine parvovirus in peripheral blood lymphocytes, monocytes, and peritoneal macrophages

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Transplacental infection of piglets with a porcine parvovirus

Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments.

Characterization of a virus that causes transient aplastic crisis.

Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Sequential changes in the relative affinity of antibodies synthesized during the immune response.

Mitogen- and viral antigen-induced transformation of lymphocytes from normal mink and from mink with progressive or nonprogressive Aleutian disease

Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus.

P304

1114-1123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI114274

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

1989-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20604076

http://www.w3.org/2001/XMLSchema#string

P698

2551923

http://www.w3.org/2001/XMLSchema#string

P921

P932

329767

http://www.w3.org/2001/XMLSchema#string